ZNF772
gene geneOn this page
Also known as DKFZp686I1569
Summary
ZNF772 (zinc finger protein 772, HGNC:33106) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 772 (Q68DY9). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 400720 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 72 total
- MANE Select transcript:
NM_001144068
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33106 |
| Approved symbol | ZNF772 |
| Name | zinc finger protein 772 |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp686I1569 |
| Ensembl gene | ENSG00000197128 |
| Ensembl biotype | protein_coding |
| Entrez | 400720 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 7 protein_coding, 1 nonsense_mediated_decay
ENST00000343280, ENST00000356584, ENST00000425074, ENST00000427512, ENST00000450712, ENST00000600175, ENST00000601768, ENST00000610548
RefSeq mRNA: 3 — MANE Select: NM_001144068
NM_001024596, NM_001144068, NM_001330613
CCDS: CCDS33133, CCDS46210, CCDS82406
Canonical transcript exons
ENST00000356584 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002243719 | 57477277 | 57477566 |
| ENSE00003472627 | 57476634 | 57476672 |
| ENSE00003579857 | 57469586 | 57474421 |
| ENSE00003679792 | 57475660 | 57475786 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 87.89.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.5300 / max 69.3169, expressed in 1579 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 182907 | 5.5300 | 1579 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| corpus callosum | UBERON:0002336 | 87.89 | gold quality |
| adrenal tissue | UBERON:0018303 | 82.94 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.32 | gold quality |
| cortical plate | UBERON:0005343 | 80.87 | gold quality |
| ganglionic eminence | UBERON:0004023 | 80.63 | gold quality |
| ventricular zone | UBERON:0003053 | 80.04 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 79.09 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.95 | gold quality |
| islet of Langerhans | UBERON:0000006 | 78.67 | gold quality |
| calcaneal tendon | UBERON:0003701 | 78.22 | gold quality |
| muscle of leg | UBERON:0001383 | 76.46 | gold quality |
| gastrocnemius | UBERON:0001388 | 76.44 | gold quality |
| muscle tissue | UBERON:0002385 | 76.19 | gold quality |
| stromal cell of endometrium | CL:0002255 | 76.02 | gold quality |
| heart left ventricle | UBERON:0002084 | 74.94 | gold quality |
| cerebellum | UBERON:0002037 | 74.82 | gold quality |
| cerebellar cortex | UBERON:0002129 | 74.73 | gold quality |
| placenta | UBERON:0001987 | 74.67 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 74.64 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 74.08 | gold quality |
| endometrium | UBERON:0001295 | 73.72 | gold quality |
| adrenal gland | UBERON:0002369 | 73.63 | gold quality |
| heart | UBERON:0000948 | 73.57 | gold quality |
| prefrontal cortex | UBERON:0000451 | 73.40 | gold quality |
| adenohypophysis | UBERON:0002196 | 72.96 | gold quality |
| pituitary gland | UBERON:0000007 | 72.73 | gold quality |
| left adrenal gland | UBERON:0001234 | 72.49 | gold quality |
| tonsil | UBERON:0002372 | 72.46 | gold quality |
| right adrenal gland | UBERON:0001233 | 72.21 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 72.17 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 5.24 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2529.1 | ZNF772 | Factors with multiple dispersed zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:39605320
miRNA regulators (miRDB)
152 targeting ZNF772, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-432-3P | 100.00 | 67.86 | 705 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-574-5P | 100.00 | 66.01 | 989 |
| HSA-MIR-223-3P | 99.99 | 70.14 | 1140 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-3910 | 99.95 | 71.13 | 2227 |
Literature-anchored findings (GeneRIF, showing 1)
- [Correlation between DNA Methylation of ZNF772 Promoter Region and Cervical Cancer]. (PMID:32385021)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zfx | ENSDARG00000074453 |
| danio_rerio | ENSDARG00000098424 | |
| mus_musculus | Zfy2 | ENSMUSG00000000103 |
| mus_musculus | Zfy1 | ENSMUSG00000053211 |
| rattus_norvegicus | Zfy1 | ENSRNOG00000053042 |
Paralogs (38): ZFX (ENSG00000005889), ZBTB11 (ENSG00000066422), ZFAT (ENSG00000066827), ZFY (ENSG00000067646), ZNF586 (ENSG00000083828), IKZF5 (ENSG00000095574), ZNF419 (ENSG00000105136), ZNF549 (ENSG00000121406), ZSCAN20 (ENSG00000121903), ZNF304 (ENSG00000131845), PRDM15 (ENSG00000141956), ZNF660 (ENSG00000144792), ZNF711 (ENSG00000147180), ZNF773 (ENSG00000152439), ZNF256 (ENSG00000152454), ZNF837 (ENSG00000152475), ZNF691 (ENSG00000164011), ZNF610 (ENSG00000167554), E4F1 (ENSG00000167967), ZNF562 (ENSG00000171466), ZNF561 (ENSG00000171469), ZNF584 (ENSG00000171574), ZIK1 (ENSG00000171649), ZNF570 (ENSG00000171827), ZSCAN2 (ENSG00000176371), ZNF552 (ENSG00000178935), ZNF154 (ENSG00000179909), ZNF792 (ENSG00000180884), ZNF793 (ENSG00000188227), ZNF548 (ENSG00000188785), ZNF79 (ENSG00000196152), ZNF418 (ENSG00000196724), ZNF583 (ENSG00000198440), ZNF480 (ENSG00000198464), ZNF551 (ENSG00000204519), ZNF134 (ENSG00000213762), ZNF587B (ENSG00000269343), ZNF8 (ENSG00000278129)
Protein
Protein identifiers
Zinc finger protein 772 — Q68DY9 (reviewed: Q68DY9)
All UniProt accessions (6): A0A087WTB1, C9J1S5, C9JFF8, Q68DY9, M0R084, M0R156
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q68DY9-1 | 1 | yes |
| Q68DY9-2 | 2 | |
| Q68DY9-3 | 3 |
RefSeq proteins (3): NP_001019767, NP_001137540, NP_001317542 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050589 | Ikaros_C2H2-ZF | Family |
Pfam: PF00096, PF01352
UniProt features (17 total): zinc finger region 10, splice variant 2, sequence variant 2, chain 1, domain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q68DY9-F1 | 65.42 | 0.12 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 31 (showing top):
TGCCTTA_MIR124A, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CEBPZ_TARGET_GENES, MIR520D_5P, MIR524_5P, MIR5582_3P, MIR95_5P, MIR548AW, MIR3688_3P, MIR6873_3P, MIR510_3P, MIR6508_5P, MIR4760_3P, MIR12124
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
402 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF772 | VN1R1 | Q9GZP7 | 952 |
| ZNF772 | ZNF487 | B1APH4 | 512 |
| ZNF772 | OR4D9 | Q8NGE8 | 503 |
| ZNF772 | OR1K1 | Q8NGR3 | 496 |
| ZNF772 | AVPR2 | P30518 | 493 |
| ZNF772 | OR52W1 | Q6IF63 | 488 |
| ZNF772 | OR2AT4 | A6NND4 | 445 |
| ZNF772 | KRTAP4-5 | Q9BYR2 | 434 |
| ZNF772 | SLCO1B7 | G3V0H7 | 417 |
| ZNF772 | RDM1 | Q8NG50 | 414 |
| ZNF772 | GOLPH3L | Q9H4A5 | 410 |
| ZNF772 | STK31 | Q9BXU1 | 409 |
| ZNF772 | TMEM121 | Q9BTD3 | 403 |
| ZNF772 | DNAJC12 | Q9UKB3 | 399 |
| ZNF772 | THOC5 | Q13769 | 398 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PEX5 | ZNF772 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF772 | PEX5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF772 | MEOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ECE1 | ZNF772 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF772 | TRIM24 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF772 | MEOX2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (8): ZNF772 (Two-hybrid), ZNF772 (Affinity Capture-RNA), ZNF772 (Affinity Capture-RNA), ZNF772 (Two-hybrid), ZNF772 (Affinity Capture-MS), ZNF772 (Affinity Capture-MS), ZNF772 (Affinity Capture-RNA), ZNF772 (Affinity Capture-MS)
ESM2 similar proteins: A0A087WUV0, A0JNB1, A1YF12, A1YG88, A2T759, B2RUI1, D3ZVT0, O43296, P0CG31, P10072, P17020, P17097, P51814, Q08ER8, Q13398, Q14590, Q3KQV3, Q3SY52, Q4V8A8, Q571J5, Q5CZA5, Q5RBX0, Q5RCD9, Q5RCX4, Q61116, Q61967, Q68DY9, Q6NX49, Q6PK81, Q80YP6, Q86UD4, Q8BFS8, Q8BV42, Q8IVP9, Q8IZ26, Q8NEK5, Q8TAU3, Q8TAW3, Q8TF47, Q8WTR7
Diamond homologs: A6NDX5, A6NN14, A6QLU5, A7MBI1, A8MQ14, B4DU55, B4DX44, O43296, O60765, O75290, O75346, O75437, O95780, P10072, P10078, P17014, P17030, P17032, P17097, P17098, P51523, P51814, P52736, P52738, P52742, Q05481, Q06730, Q06732, Q14586, Q14929, Q15928, Q16587, Q29RZ4, Q2KI58, Q3KNS6, Q3V080, Q3ZCX4, Q49AA0, Q4R6C2, Q4V8A8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
72 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 59 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
959 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:57475654:CCTT:C | donor_loss | 0.9900 |
| 19:57475655:CTTAC:C | donor_loss | 0.9900 |
| 19:57475656:TTA:T | donor_loss | 0.9900 |
| 19:57475657:TACC:T | donor_loss | 0.9900 |
| 19:57475658:A:AC | donor_gain | 0.9900 |
| 19:57475658:A:C | donor_loss | 0.9900 |
| 19:57475658:A:G | donor_loss | 0.9900 |
| 19:57475658:AC:A | donor_gain | 0.9900 |
| 19:57475659:C:CA | donor_loss | 0.9900 |
| 19:57475659:C:CC | donor_gain | 0.9900 |
| 19:57475659:CC:C | donor_gain | 0.9900 |
| 19:57475783:GCCC:G | acceptor_gain | 0.9900 |
| 19:57475784:CCCC:C | acceptor_gain | 0.9900 |
| 19:57475791:C:CT | acceptor_gain | 0.9900 |
| 19:57475791:C:T | acceptor_gain | 0.9900 |
| 19:57475784:CCC:C | acceptor_gain | 0.9800 |
| 19:57475785:CCC:C | acceptor_gain | 0.9800 |
| 19:57475797:C:CT | acceptor_gain | 0.9800 |
| 19:57476630:TCACC:T | donor_loss | 0.9800 |
| 19:57476633:C:CT | donor_loss | 0.9800 |
| 19:57476669:GAACC:G | acceptor_loss | 0.9800 |
| 19:57476670:AACC:A | acceptor_loss | 0.9800 |
| 19:57476670:AACCT:A | acceptor_loss | 0.9800 |
| 19:57476671:ACCT:A | acceptor_loss | 0.9800 |
| 19:57476672:CCT:C | acceptor_loss | 0.9800 |
| 19:57476673:CT:C | acceptor_loss | 0.9800 |
| 19:57476673:CTGTG:C | acceptor_loss | 0.9800 |
| 19:57476674:T:C | acceptor_loss | 0.9800 |
| 19:57476674:T:G | acceptor_loss | 0.9800 |
| 19:57475782:TGCCC:T | acceptor_gain | 0.9700 |
AlphaMissense
3033 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:57473331:G:C | F471L | 0.999 |
| 19:57473331:G:T | F471L | 0.999 |
| 19:57473333:A:G | F471L | 0.999 |
| 19:57473415:A:C | F443L | 0.999 |
| 19:57473415:A:T | F443L | 0.999 |
| 19:57473417:A:G | F443L | 0.999 |
| 19:57473482:A:G | L421P | 0.998 |
| 19:57473751:A:C | F331L | 0.998 |
| 19:57473751:A:T | F331L | 0.998 |
| 19:57473753:A:G | F331L | 0.998 |
| 19:57473388:A:C | H452Q | 0.997 |
| 19:57473388:A:T | H452Q | 0.997 |
| 19:57473416:A:G | F443S | 0.997 |
| 19:57473712:G:C | H344Q | 0.997 |
| 19:57473712:G:T | H344Q | 0.997 |
| 19:57473722:T:G | Q341P | 0.997 |
| 19:57473734:A:G | L337P | 0.997 |
| 19:57473314:A:G | L477P | 0.996 |
| 19:57473376:G:C | H456Q | 0.996 |
| 19:57473376:G:T | H456Q | 0.996 |
| 19:57473390:G:C | H452D | 0.996 |
| 19:57473398:A:G | L449P | 0.996 |
| 19:57473472:A:C | H424Q | 0.996 |
| 19:57473472:A:T | H424Q | 0.996 |
| 19:57473499:A:C | F415L | 0.996 |
| 19:57473499:A:T | F415L | 0.996 |
| 19:57473501:A:G | F415L | 0.996 |
| 19:57473724:A:C | H340Q | 0.996 |
| 19:57473724:A:T | H340Q | 0.996 |
| 19:57473835:A:C | F303L | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000274871 (19:57470535 A>G), RS1000279280 (19:57474746 G>A,T), RS1000718337 (19:57469712 T>C), RS1000750879 (19:57469967 A>G), RS1000787461 (19:57477389 G>C,T), RS1001150241 (19:57478385 T>G), RS1001503476 (19:57473051 T>C), RS1001592989 (19:57476815 C>G), RS1001958957 (19:57476987 G>A,C), RS1002323643 (19:57478015 C>T), RS1002403421 (19:57471518 C>G,T), RS1003205131 (19:57471919 G>A), RS1003411443 (19:57470235 C>A,T), RS1003493872 (19:57478189 G>C), RS1003604000 (19:57478552 A>C,G,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression | 2 |
| methacrylaldehyde | affects cotreatment, decreases expression, increases oxidation, increases abundance | 2 |
| Acrolein | increases abundance, affects cotreatment, decreases expression, increases oxidation | 2 |
| Ozone | decreases expression, increases oxidation, increases abundance, affects cotreatment | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| alpha-pinene | decreases expression, increases oxidation, increases abundance, affects cotreatment | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| abrine | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance, increases oxidation, affects cotreatment | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Potassium Chloride | decreases expression, decreases response to substance | 1 |
| Dronabinol | decreases expression, decreases response to substance | 1 |
| Urethane | decreases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| Volatile Organic Compounds | affects cotreatment, decreases expression, increases oxidation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.